Advertisement

Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes

  • S. M. Brichard
Chapter
Part of the Developments in Molecular and Cellular Biochemistry book series (DMCB, volume 16)

Abstract

Vanadium is a trace element that has raised increasing interest in diabetology since the discovery of its insulin-like properties in vitro and in vivo. This brief article reviews the most recent data concerning the beneficial effects of vanadium compounds on fuel homeostasis in animal models of insulinopenic (Type I) or insulin-resistant (Type II) diabetes. These studies open obvious therapeutic possibilities in diabetes, and more particularly, in states of insulin resistance.

Key words

vanadium compounds insulin-dependent diabetes insulin-independent diabetes gene expression in liver 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brichard SM, Lederer J, Henquin JC: The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes? Diabete Metab 17: 435 440, 1991Google Scholar
  2. 2.
    Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474–1477, 1985PubMedCrossRefGoogle Scholar
  3. 3.
    Meyerovitch J, Farfel Z, Sack J, Shechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J Biol Chem 262: 6658–6662, 1987PubMedGoogle Scholar
  4. 4.
    Gil J, Miralpeix M, Carreras J, Bartrons R: Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem 263: 1868–1871, 1988PubMedGoogle Scholar
  5. 5.
    Brichard SM, Okitolonda W, Henquin JC: Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048–2053, 1988PubMedCrossRefGoogle Scholar
  6. 6.
    Blondel O, Bailbe D, Portha B: In vivo insulin resistance in streptozotocin-diabetic rats — evidence for reversal following oral vanadate treatment. Diabetologia 32: 185–190, 1989PubMedCrossRefGoogle Scholar
  7. 7.
    Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH: Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol 257: H904–H911, 1989PubMedGoogle Scholar
  8. 8.
    Pugazhenthi S, Khandelwal RL: Insulinlike effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozocin-induced diabetic rats. Diabetes 39: 821–827, 1990PubMedCrossRefGoogle Scholar
  9. 9.
    Venkatesan N, AvidanA, Davidson MB: Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity. Diabetes 40: 492–498, 1991PubMedCrossRefGoogle Scholar
  10. 10.
    Malabu UH, Dryden S, McCarthy HD, Kilpatrick A, Williams G: Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attribuable entirely to its suppression of feeding. Diabetes 43: 9–15, 1994PubMedCrossRefGoogle Scholar
  11. 11.
    Henquin JC, Carton F, Ongemba LN, Becker DJ: Improvement of mild hypoinsulinaemic diabetes in the rat by low doses of vanadium. J Endocrinol 142: 555–561, 1994PubMedCrossRefGoogle Scholar
  12. 12.
    Granner D, Pilkis S: The genes of hepatic glucose metabolism. J Biol Chem 265: 10173–10176, 1990PubMedGoogle Scholar
  13. 13.
    Brichard SM, Desbuquois B, Girard J: Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2. Mol Cell Endocrinol 91: 91–97, 1993PubMedCrossRefGoogle Scholar
  14. 14.
    Valera A, Rodriguez-Gil JE, Bosch F: Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats. J Clin Invest 92: 4–11, 1993PubMedCrossRefGoogle Scholar
  15. 15.
    Miralpeix M, Carballo E, Bartrons RI, Crepin K, Hue L, Rousseau GG: Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA. Diabetologia 35: 243–248, 1992PubMedCrossRefGoogle Scholar
  16. 16.
    Brichard SM, Henquin JC, Girard J: Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism. Diabetologia 36: 292–298, 1993PubMedCrossRefGoogle Scholar
  17. 17.
    Miralpeix M, Decaux JF, Kahn A, Bartrons R: Vanadate induction of L-type pyruvate kinase mRNA in adult rat hepatocytes in primary cultures. Diabetes 40: 462–464, 1991PubMedCrossRefGoogle Scholar
  18. 18.
    Bosch F, Hatzoglou M, Park EA, Hanson RW: Vanadate inhibits expression of the gene for phosphoenolpyruvate carboxykinase (GTP) in rat hepatoma cells. J Biol Chem 265: 13677–13682, 1990PubMedGoogle Scholar
  19. 19.
    Brichard SM, Ongemba LN, Girard J, Henquin JC: Tissue-specific correction of lipogenic enzyme gene expression in diabetic rats given vanadate. Diabetologia 37: 1065–1072, 1994PubMedCrossRefGoogle Scholar
  20. 20.
    Foufelle F, Gouhot B, Pegorier JP, Perdereau D, Girard J, Ferre P: Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue. A role for glucose 6-phosphate. J Biol Chem 267: 20543–20546, 1992PubMedGoogle Scholar
  21. 21.
    Iritani N: Nutritional and hormonal regulation of lipogenic-enzyme gene expression in rat liver. Eur J Biochem 205: 433–442, 1992PubMedCrossRefGoogle Scholar
  22. 22.
    Rossetti L, Laughlin MR: Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 84: 892–899, 1989PubMedCrossRefGoogle Scholar
  23. 23.
    Strout HV, Vicario PP, Biswas C, Saperstein R, Brady EJ, Pilch PF, Berger J: Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin responsive glucose transporter in skeletal muscle. Endocrinology 126: 2728–2732, 1990PubMedCrossRefGoogle Scholar
  24. 24.
    Brichard SM, Pottier AM, Henquin JC: Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 125: 2510–2516, 1989PubMedCrossRefGoogle Scholar
  25. 25.
    Brichard SM, Bailey CJ, Henquin JC: Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes 39: 1326–1332, 1990PubMedCrossRefGoogle Scholar
  26. 26.
    Meyerovitch J, Rothenberg P, Shechter Y, Bonner-Weir S, Kahn CR: Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. J Clin Invest 87: 1286–1294, 1991PubMedCrossRefGoogle Scholar
  27. 27.
    Pugazhenthi S, Angel JF, Khandelwal RL: Long-term effects of vanadate on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice. Metabolism 40: 941–946, 1991PubMedCrossRefGoogle Scholar
  28. 28.
    Brichard SM, Ongemba LN, Kolanowski J, Henquin JC: The influence of vanadate on insulin counter-regulatory hormones in obese fa/fa rats. J Endocrinol 131: 185–191, 1991PubMedCrossRefGoogle Scholar
  29. 29.
    Brichard SM, Assimacopoulos-Jeannet F, Jeanrenaud B: Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression. Endocrinology 131: 311–317, 1992PubMedCrossRefGoogle Scholar
  30. 30.
    Brichard SM, Ongemba LN, Henquin JC: Oral vanadate decreases muscle insulin resistance in obese fa/fa rats. Diabetologia 35: 522–527, 1992PubMedCrossRefGoogle Scholar
  31. 31.
    Kraegen EW, James DE, Jenkins AB, Chisholm DJ: Dose response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248: E353–E362, 1985PubMedGoogle Scholar
  32. 32.
    Morgan HE, Cadenas E, Regen DM, Park CR: Regulation of glucose uptake in muscle. II. Rate limiting steps and effect. J Biol Chem 236: 262–268, 1961PubMedGoogle Scholar
  33. 33.
    Friedman JE, Sherman WN, Reed MJ, Elton CW, Dohm GL: Exercise training increases glucose transporter protein GLUT4 in skeletal muscle of obese Zucker (fa/fa) rats. FEBS Lett 268: 13–16, 1990PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • S. M. Brichard
    • 1
  1. 1.Unité d’Endocrinologie et MétabolismeUniversity of Louvain, Faculty of Medicine, UCL 55.30BrusselsBelgium

Personalised recommendations